| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| MAZEMaze Therapeutics, Inc. | 1.92B | 39.81 | 511.70 | 31.18% | -33.24% | 3.91% | 0.14 | |
| GNFTGenfit S.A. | 313.52M | 6.27 | 209 | 134.56% | -14.12% | -31.42% | 4.54% | 0.90 |
| GYREGyre Therapeutics, Inc. | 741.77M | 7.70 | 154 | -6.78% | 6.2% | 4.84% | 0.02 | |
| TVRDTvardi Therapeutics, Inc. | 42.31M | 4.51 | -0.10 | -65.96% | -317.54% | -63.46% | ||
| UNCYUnicycive Therapeutics, Inc. | 134.75M | 6.27 | -1.12 | -100% | -89.15% | 0.10 | ||
| GLTOGalecto, Inc. | 38.32M | 23.95 | -1.29 | -237.68% | 0.00 | |||
| IVAInventiva S.A. | 1.17B | 6.12 | -1.73 | -47.37% | -13.75% | |||
| AKBAAkebia Therapeutics, Inc. | 355.59M | 1.34 | -4.06 | -17.7% | -7.07% | -38.24% |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 13.22M | 7.26M | 2.71M | 8.07M | 739.63K | 12.85M | 15.94M | 17.49M | 14M |
| Revenue Growth % | - | -0.45% | -0.63% | 1.98% | -0.91% | 16.38% | 0.24% | 0.1% | -0.2% |
| Cost of Goods Sold | 918.78K | 319.76K | 121.39K | 807.19K | 237.71K | 3.02M | 2.86M | 2.89M | 5.88M |
| COGS % of Revenue | 0.07% | 0.04% | 0.04% | 0.1% | 0.32% | 0.24% | 0.18% | 0.17% | 0.42% |
| Gross Profit | 12.3M | 6.94M | 2.59M | 7.26M | 501.92K | 9.83M | 13.08M | 14.6M | 8.12M |
| Gross Margin % | 0.93% | 0.96% | 0.96% | 0.9% | 0.68% | 0.76% | 0.82% | 0.83% | 0.58% |
| Gross Profit Growth % | - | -0.44% | -0.63% | 1.81% | -0.93% | 18.58% | 0.33% | 0.12% | -0.44% |
| Operating Expenses | 28.16M | 34.97M | 37.45M | 54.09M | 59.59M | 43.63M | 51.85M | 87.98M | 129.41M |
| OpEx % of Revenue | 2.13% | 4.82% | 13.84% | 6.7% | 80.57% | 3.39% | 3.25% | 5.03% | 9.25% |
| Selling, General & Admin | 4.84M | 10.21M | 8.75M | 13.6M | 27.37M | 23.11M | 32.41M | 44.74M | 81.57M |
| SG&A % of Revenue | 0.37% | 1.41% | 3.23% | 1.68% | 37% | 1.8% | 2.03% | 2.56% | 5.83% |
| Research & Development | 23.32M | 24.75M | 28.7M | 40.49M | 32.22M | 20.52M | 19.43M | 43.24M | 47.84M |
| R&D % of Revenue | 1.76% | 3.41% | 10.6% | 5.02% | 43.57% | 1.6% | 1.22% | 2.47% | 3.42% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -15.86M | -28.03M | -34.87M | -46.82M | -59.09M | -33.8M | -38.77M | -73.38M | -121.29M |
| Operating Margin % | -1.2% | -3.86% | -12.88% | -5.8% | -79.89% | -2.63% | -2.43% | -4.2% | -8.67% |
| Operating Income Growth % | - | -0.77% | -0.24% | -0.34% | -0.26% | 0.43% | -0.15% | -0.89% | -0.65% |
| EBITDA | -15.21M | -27.1M | -33.32M | -44.03M | -55.97M | -28.18M | -35.12M | -71.21M | -119.1M |
| EBITDA Margin % | -1.15% | -3.73% | -12.31% | -5.45% | -75.68% | -2.19% | -2.2% | -4.07% | -8.51% |
| EBITDA Growth % | - | -0.78% | -0.23% | -0.32% | -0.27% | 0.5% | -0.25% | -1.03% | -0.67% |
| D&A (Non-Cash Add-back) | 651.56K | 931.93K | 1.54M | 2.79M | 3.12M | 5.61M | 3.65M | 2.18M | 2.2M |
| EBIT | -15.85M | -16.14M | -34.15M | -46.21M | -58.9M | -33.82M | -38.68M | -72.23M | -117.91M |
| Net Interest Income | -70.96K | -13.01M | -18.68M | -759.91K | -673.64K | -729K | -1.25M | -2.81M | -4.83M |
| Interest Income | 14.91K | 268 | 304.98K | 613.72K | 184.36K | 33K | 1.09M | 3.47M | 7.65M |
| Interest Expense | 85.86K | 13.01M | 18.99M | 1.37M | 858K | 762K | 2.34M | 6.27M | 12.49M |
| Other Income/Expense | -70.96K | -1.13M | -18.27M | -759.91K | -673.64K | -782K | -2.25M | -5.12M | -9.1M |
| Pretax Income | -15.93M | -29.15M | -53.14M | -47.58M | -59.76M | -34.58M | -41.02M | -78.5M | -130.39M |
| Pretax Margin % | -1.21% | -4.02% | -19.63% | -5.89% | -80.8% | -2.69% | -2.57% | -4.49% | -9.32% |
| Income Tax | 14.91K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 1% | 1% | 1% | 1% | 1% | 1% | 1% | 1% | 1% |
| Net Income | -15.93M | -29.15M | -53.14M | -47.58M | -59.76M | -34.58M | -41.02M | -78.5M | -130.39M |
| Net Margin % | -1.21% | -4.02% | -19.63% | -5.89% | -80.8% | -2.69% | -2.57% | -4.49% | -9.32% |
| Net Income Growth % | - | -0.83% | -0.82% | 0.1% | -0.26% | 0.42% | -0.19% | -0.91% | -0.66% |
| Net Income (Continuing) | -15.93M | -29.15M | -53.14M | -47.58M | -59.76M | -34.58M | -41.02M | -78.5M | -130.39M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.86 | -3.40 | -7.42 | -2.51 | -1.76 | -0.70 | -0.67 | -1.21 | -1.66 |
| EPS Growth % | - | -0.83% | -1.18% | 0.66% | 0.3% | 0.6% | 0.04% | -0.81% | -0.37% |
| EPS (Basic) | -1.86 | -3.40 | -7.42 | -2.51 | -1.76 | -0.70 | -0.67 | -1.21 | -1.66 |
| Diluted Shares Outstanding | 8.59M | 8.59M | 7.16M | 18.48M | 33.89M | 49.68M | 60.96M | 64.99M | 78.71M |
| Basic Shares Outstanding | 8.59M | 8.59M | 7.16M | 18.48M | 33.89M | 49.68M | 60.96M | 64.99M | 78.71M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 3.15M | 5.48M | 40.03M | 56.39M | 66.07M | 61.28M | 99.81M | 89.9M | 185.1M |
| Cash & Short-Term Investments | 1.44M | 3.42M | 39.53M | 55.8M | 65.32M | 57.49M | 93.28M | 83.68M | 176.48M |
| Cash Only | 1.44M | 3.42M | 39.53M | 55.8M | 65.32M | 57.49M | 93.28M | 83.68M | 176.48M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 1.24M | 1.62M | 272.56K | 0 | 0 | 2.99M | 5.02M | 4.06M | 2.72M |
| Days Sales Outstanding | 34.21 | 81.58 | 36.75 | - | - | 84.91 | 114.92 | 84.76 | 70.91 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 241K |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | 14.96 |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 | -381 | 1.51M | 2.16M | 5.67M |
| Total Non-Current Assets | 5.34M | 9.36M | 9.39M | 12.46M | 33.46M | 32.45M | 29.39M | 28.43M | 45.21M |
| Property, Plant & Equipment | 4.35M | 8.24M | 8.13M | 12.08M | 9.45M | 7.43M | 6.25M | 6.18M | 12.48M |
| Fixed Asset Turnover | 3.04x | 0.88x | 0.33x | 0.67x | 0.08x | 1.73x | 2.55x | 2.83x | 1.12x |
| Goodwill | 0 | 0 | 0 | 0 | 3.9M | 3.9M | 3.9M | 3.9M | 3.9M |
| Intangible Assets | 0 | 0 | 0 | 0 | 5.53M | 4.39M | 3.73M | 3.43M | 3.16M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 992.72K | 1.12M | 1.26M | 378.04K | 14.57M | 16.73M | 15.51M | 14.92M | 25.66M |
| Total Assets | 8.49M | 14.84M | 49.42M | 68.84M | 99.53M | 93.73M | 129.2M | 118.33M | 230.31M |
| Asset Turnover | 1.56x | 0.49x | 0.05x | 0.12x | 0.01x | 0.14x | 0.12x | 0.15x | 0.06x |
| Asset Growth % | - | 0.75% | 2.33% | 0.39% | 0.45% | -0.06% | 0.38% | -0.08% | 0.95% |
| Total Current Liabilities | 12.09M | 30.52M | 8.25M | 16.87M | 11.74M | 7.33M | 8.8M | 18.55M | 41.78M |
| Accounts Payable | 2.41M | 4.42M | 3.24M | 3.5M | 3.73M | 1.07M | 2.2M | 1.4M | 4.69M |
| Days Payables Outstanding | 956.32 | 5.05K | 9.73K | 1.58K | 5.73K | 129.19 | 280.48 | 176.43 | 291.12 |
| Short-Term Debt | 2.9M | 15.61M | 316.91K | 5.59M | 0 | 0 | 0 | 2.62M | 18.02M |
| Deferred Revenue (Current) | 1000K | 1000K | 1000K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.16M | 2.22M | 268.6K | 1.29M | 5.03M | 3.16M | 2.86M | 8.54M | 18.66M |
| Current Ratio | 0.26x | 0.18x | 4.85x | 3.34x | 5.63x | 8.36x | 11.34x | 4.85x | 4.43x |
| Quick Ratio | 0.26x | 0.18x | 4.85x | 3.34x | 5.63x | 8.36x | 11.34x | 4.85x | 4.42x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | -205.25 |
| Total Non-Current Liabilities | 14.64M | 18.01M | 22.48M | 17.02M | 16.71M | 21.14M | 29.98M | 52.49M | 111.26M |
| Long-Term Debt | 5.22M | 5.56M | 11.63M | 10.29M | 10.29M | 10.41M | 19.88M | 43.42M | 97.37M |
| Capital Lease Obligations | 243.43K | 510.63K | 376.08K | 6.73M | 5.26M | 4.58M | 3.5M | 2.36M | 6.59M |
| Deferred Tax Liabilities | -243.43K | -510.63K | -376.08K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 456.9K | 6.42M | 2.41M | 0 | 1.15M | 6.14M | 6.59M | 6.71M | 7.3M |
| Total Liabilities | 26.73M | 48.54M | 30.73M | 33.89M | 28.45M | 28.46M | 38.78M | 71.04M | 153.04M |
| Total Debt | 8.68M | 22.15M | 12.77M | 24.42M | 17.14M | 16.08M | 24.46M | 49.54M | 122.39M |
| Net Debt | 7.24M | 18.73M | -26.76M | -31.38M | -48.17M | -41.41M | -68.82M | -34.14M | -54.09M |
| Debt / Equity | - | - | 0.68x | 0.70x | 0.24x | 0.25x | 0.27x | 1.05x | 1.58x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -184.74x | -2.15x | -1.84x | -34.09x | -68.87x | -44.35x | -16.58x | -11.70x | -9.71x |
| Total Equity | -18.25M | -33.69M | 18.69M | 34.95M | 71.09M | 65.27M | 90.42M | 47.29M | 77.28M |
| Equity Growth % | - | -0.85% | 1.55% | 0.87% | 1.03% | -0.08% | 0.39% | -0.48% | 0.63% |
| Book Value per Share | -2.12 | -3.92 | 2.61 | 1.89 | 2.10 | 1.31 | 1.48 | 0.73 | 0.98 |
| Total Shareholders' Equity | -18.25M | -33.69M | 18.69M | 34.95M | 71.09M | 65.27M | 90.42M | 47.29M | 77.28M |
| Common Stock | 554 | 570 | 15.52K | 28.23K | 43.34K | 52K | 64K | 69K | 85K |
| Retained Earnings | -84.26M | -113.41M | -167.05M | -215.24M | -275M | -309.58M | -350.6M | -429.1M | -559.49M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -6.87M | -7.8M | -9.3M | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -13.95M | -24.29M | -31.83M | -48.28M | -54.14M | -34.03M | -28.59M | -41.56M | -93.42M |
| Operating CF Margin % | -1.06% | -3.35% | -11.76% | -5.98% | -73.21% | -2.65% | -1.79% | -2.38% | -6.67% |
| Operating CF Growth % | - | -0.74% | -0.31% | -0.52% | -0.12% | 0.37% | 0.16% | -0.45% | -1.25% |
| Net Income | -15.93M | -29.15M | -53.14M | -47.58M | -59.76M | -34.58M | -41.02M | -78.5M | -130.39M |
| Depreciation & Amortization | 651.56K | 931.93K | 1.54M | 2.57M | 3.13M | 5.61M | 3.65M | 2.18M | 2.2M |
| Stock-Based Compensation | 347.44K | 514.09K | 2.2M | 3.38M | 3.95M | 6.75M | 9.3M | 10.09M | 18.81M |
| Deferred Taxes | 0 | -11.88M | -415.41K | 6.59K | 10.8K | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 391.65K | 14.91M | 17.69M | 300.9K | 235.53K | 566K | 1.64M | 18.8M | 20.76M |
| Working Capital Changes | 596.41K | 389.67K | 294.85K | -6.95M | -1.71M | -12.38M | -2.16M | 5.87M | -4.79M |
| Change in Receivables | 2.53M | -328.46K | 1.35B | 272.56K | 0 | -2.99M | -2.03M | 956K | 1.34M |
| Change in Inventory | 0 | 0 | -1.35B | -272.56K | 0 | 0 | 0 | 0 | -241K |
| Change in Payables | 1.31M | 1.87M | -1.28M | 294.51K | -297.16K | -7.56M | 814K | -1.15M | 2.33M |
| Cash from Investing | -2.89M | -2.54M | -870.94K | -1.85M | 247.91K | -107K | -587K | -11.29M | -8.44M |
| Capital Expenditures | -2.89M | -2.54M | -870.94K | -1.85M | -752.09K | -107K | -592K | -1.29M | -4.95M |
| CapEx % of Revenue | 0.22% | 0.35% | 0.32% | 0.23% | 1.02% | 0.01% | 0.04% | 0.07% | 0.35% |
| Acquisitions | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -10M | -3.49M |
| Cash from Financing | 6.11M | 28.81M | 68.82M | 66.39M | 63.42M | 26.32M | 64.96M | 43.25M | 194.66M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - |
| Other Financing | 445.47K | -1.3M | -2.18M | 0 | -1.04M | 5.03M | 1.55M | -363K | 3.61M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -16.83M | -26.83M | -32.7M | -50.13M | -54.9M | -34.14M | -29.18M | -42.85M | -98.37M |
| FCF Margin % | -1.27% | -3.7% | -12.08% | -6.21% | -74.22% | -2.66% | -1.83% | -2.45% | -7.03% |
| FCF Growth % | - | -0.59% | -0.22% | -0.53% | -0.1% | 0.38% | 0.15% | -0.47% | -1.3% |
| FCF per Share | -1.96 | -3.13 | -4.57 | -2.71 | -1.62 | -0.69 | -0.48 | -0.66 | -1.25 |
| FCF Conversion (FCF/Net Income) | 0.88x | 0.83x | 0.60x | 1.01x | 0.91x | 0.98x | 0.70x | 0.53x | 0.72x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 423K | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | -284.34% | -177.43% | -112.72% | -50.72% | -52.69% | -114.01% | -209.35% |
| Return on Invested Capital (ROIC) | - | - | - | - | -334.73% | -108.41% | -127.95% | -316.75% | -500.72% |
| Gross Margin | 93.05% | 95.59% | 95.52% | 90% | 67.86% | 76.48% | 82.06% | 83.49% | 58% |
| Net Margin | -120.56% | -401.68% | -1962.92% | -589.48% | -8080.11% | -269.03% | -257.39% | -448.89% | -931.65% |
| Debt / Equity | - | - | 0.68x | 0.70x | 0.24x | 0.25x | 0.27x | 1.05x | 1.58x |
| Interest Coverage | -184.74x | -2.15x | -1.84x | -34.09x | -68.87x | -44.35x | -16.58x | -11.70x | -9.71x |
| FCF Conversion | 0.88x | 0.83x | 0.60x | 1.01x | 0.91x | 0.98x | 0.70x | 0.53x | 0.72x |
| Revenue Growth | - | -45.08% | -62.7% | 198.2% | -90.84% | 1637.77% | 23.98% | 9.75% | -19.97% |
| 2018 | 2019 | 2020 | |
|---|---|---|---|
| Promotion Agreement | - | - | 739.63K |
| Promotion Agreement Growth | - | - | - |
| Research and Development Services | - | 200 | - |
| Research and Development Services Growth | - | - | - |
| Non-Refundable Payments - Up-front Payments | - | 6.73M | - |
| Non-Refundable Payments - Up-front Payments Growth | - | - | - |
| Non-Refundable Payments - Milestones | - | 1.35M | - |
| Non-Refundable Payments - Milestones Growth | - | - | - |
| Research And Development Services | 1.49M | - | - |
| Research And Development Services Growth | - | - | - |
| Collaboration And Licensing Non Refundable Upfront Payments | 1.17M | - | - |
| Collaboration And Licensing Non Refundable Upfront Payments Growth | - | - | - |
| Collaboration And Licensing Milestones | 45.06K | - | - |
| Collaboration And Licensing Milestones Growth | - | - | - |
Liquidia Corporation (LQDA) reported $69.2M in revenue for fiscal year 2024. This represents a 424% increase from $13.2M in 2016.
Liquidia Corporation (LQDA) saw revenue decline by 20.0% over the past year.
Liquidia Corporation (LQDA) reported a net loss of $121.8M for fiscal year 2024.
Liquidia Corporation (LQDA) has a return on equity (ROE) of -209.4%. Negative ROE indicates the company is unprofitable.
Liquidia Corporation (LQDA) had negative free cash flow of $107.8M in fiscal year 2024, likely due to heavy capital investments.